OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on July 10, 2012, with the earliest event reported on that date. The filing primarily addresses executive leadership changes within the finance department, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to executive compensation:
- New CFO Base Salary: $275,000 annually for Juan F. Rodriguez.
- Outgoing CFO Consulting Fee: $310,000 total, payable over an 18-month period for Rao Uppaluri.
- Equity Grant: 300,000 stock options granted to Mr. Rodriguez, vesting in four equal annual installments starting July 16, 2013.
Material Changes
The material change reported is the transition of the Chief Financial Officer role effective July 16, 2012:
- Departure: Rao Uppaluri retired as Senior Vice President and CFO. He will transition to a consulting role for 18 months.
- Appointment: Juan F. Rodriguez was appointed Senior Vice President and CFO. He brings experience from Cognitec Systems GmbH, Kos Pharmaceuticals, Inc., and Arthur Andersen LLP.
- Compensation Adjustment: The new CFO's base salary is $35,000 lower than the outgoing CFO's current salary, though the outgoing CFO receives accelerated vesting of unvested stock options.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of material risks and contingencies. It notes that a press release was issued on July 16, 2012, regarding these appointments, but the text of that release is not included in this summary.
Key Facts for Investor Verification
- Verify the effective date of the CFO transition (July 16, 2012) and the interim financial leadership arrangement.
- Confirm the total cost of the outgoing CFO's retirement package, including the accelerated vesting of stock options.
- Review the vesting schedule and strike price of the 300,000 options granted to the new CFO.
- Check subsequent filings for any impact on the company's financial reporting or internal controls during the transition period.